Publications by authors named "Peter End"

8Publications

New Perspectives on Drug-Induced Liver Injury Risk Assessment of Acyl Glucuronides.

Chem Res Toxicol 2020 Jul 29;33(7):1551-1560. Epub 2020 Jun 29.

PK Sciences, Novartis Institutes for Biomedical Research, Novartis Campus, 4052 Basel, Switzerland.

View Article and Find Full Text PDF
July 2020

Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro.

Drug Metab Dispos 2017 07 25;45(7):817-825. Epub 2017 Apr 25.

Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland (D.P., H.M.W., Y.J., V.J.E., U.G., P.E., R.W., F.E., G.C.); PRA International, Early Development Services, Zuidlaren, the Netherlands (J.J.v.L.).

View Article and Find Full Text PDF
July 2017

Drug-induced liver injury: recent advances in diagnosis and risk assessment.

Gut 2017 06 23;66(6):1154-1164. Epub 2017 Mar 23.

National Institute for Health Research (NIHR), Nottingham Digestive Diseases Biomedical Research Unit, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.

View Article and Find Full Text PDF
June 2017

High-Throughput Melanin-Binding Affinity and In Silico Methods to Aid in the Prediction of Drug Exposure in Ocular Tissue.

J Pharm Sci 2015 Dec 2;104(12):3997-4001. Epub 2015 Nov 2.

Novartis Institutes for BioMedical Research, Global Discovery Chemistry, Cambridge, Massachusetts 02139.

View Article and Find Full Text PDF
December 2015